Citadel Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $753K | Buy |
97,600
+11,400
| +13% | +$83.2K | ﹤0.01% | 8345 |
|
|
2025
Q4 | $528K | Buy |
86,200
+35,300
| +69% | +$381K | ﹤0.01% | 8897 |
|
|
2025
Q3 | $938K | Buy |
50,900
+15,200
| +43% | +$244K | ﹤0.01% | 7667 |
|
|
2025
Q2 | $464K | Sell |
35,700
-17,400
| -33% | -$206K | ﹤0.01% | 8803 |
|
|
2025
Q1 | $562K | Buy |
53,100
+1,500
| +3% | +$23.8K | ﹤0.01% | 8229 |
|
|
2024
Q4 | $876K | Buy |
51,600
+37,900
| +277% | +$713K | ﹤0.01% | 7330 |
|
|
2024
Q3 | $318K | Buy |
13,700
+400
| +3% | +$8.56K | ﹤0.01% | 9212 |
|
|
2024
Q2 | $324K | Buy |
13,300
+2,600
| +24% | +$78.8K | ﹤0.01% | 8984 |
|
|
2024
Q1 | $361K | Sell |
10,700
-12,300
| -53% | -$436K | ﹤0.01% | 9068 |
|
|
2023
Q4 | $725K | Buy |
23,000
+9,000
| +64% | +$214K | ﹤0.01% | 7316 |
|
|
2023
Q3 | $358K | Sell |
14,000
-12,500
| -47% | -$385K | ﹤0.01% | 8795 |
|
|
2023
Q2 | $760K | Buy |
26,500
+7,200
| +37% | +$196K | ﹤0.01% | 7029 |
|
|
2023
Q1 | $463K | Buy |
19,300
+3,700
| +24% | +$66.4K | ﹤0.01% | 8478 |
|
|
2022
Q4 | $265K | Buy |
+15,600
| New | +$272K | ﹤0.01% | 9588 |
|
|
2022
Q3 | – | Sell |
-16,700
| Closed | -$263K | – | 12549 |
|
|
2022
Q2 | $263K | Sell |
16,700
-13,700
| -45% | -$269K | ﹤0.01% | 10113 |
|
|
2022
Q1 | $820K | Buy |
30,400
+14,700
| +94% | +$375K | ﹤0.01% | 8165 |
|
|
2021
Q4 | $581K | Sell |
15,700
-19,000
| -55% | -$774K | ﹤0.01% | 9320 |
|
|
2021
Q3 | $1.66M | Buy |
34,700
+15,700
| +83% | +$704K | ﹤0.01% | 6839 |
|
|
2021
Q2 | $643K | Sell |
19,000
-44,300
| -70% | -$1.5M | ﹤0.01% | 9443 |
|
|
2021
Q1 | $2.61M | Sell |
63,300
-11,300
| -15% | -$674K | ﹤0.01% | 5767 |
|
|
2020
Q4 | $3.24M | Buy |
74,600
+30,200
| +68% | +$2.05M | ﹤0.01% | 4462 |
|
|
2020
Q3 | $1.91M | Buy |
44,400
+4,700
| +12% | +$233K | ﹤0.01% | 4808 |
|
|
2020
Q2 | $1.86M | Buy |
+39,700
| New | +$1.37M | ﹤0.01% | 4718 |
|
|
2017
Q1 | – | Sell |
-2,071
| Closed | -$30K | – | 7401 |
|
|
2016
Q4 | $30K | Buy |
+2,071
| New | +$31K | ﹤0.01% | 6988 |
|
|
2016
Q1 | – | Sell |
-171
| Closed | -$8K | – | 6714 |
|
|
2015
Q4 | $8K | Buy |
+171
| New | +$7.7K | ﹤0.01% | 8332 |
|
|
2015
Q3 | – | Sell |
-471
| Closed | -$22K | – | 8854 |
|
|
2015
Q2 | $22K | Sell |
471
-600
| -56% | -$27.5K | ﹤0.01% | 8100 |
|
|
2015
Q1 | $42K | Buy |
1,071
+900
| +526% | +$39.6K | ﹤0.01% | 7482 |
|
|
2014
Q4 | $4K | Sell |
171
-1,986
| -92% | -$63.2K | ﹤0.01% | 8297 |
|
|
2014
Q3 | $233K | Buy |
+2,157
| New | +$281K | ﹤0.01% | 5562 |
|
Other funds holding ARCT
AIM
NAMA
VCM
VPM
